Reductions Seen in HbA1c, Body Weight With Once-Weekly Tirzepatide
FRIDAY, Oct. 6, 2023 (HealthDay News) — For patients with inadequately controlled type 2 diabetes, once-weekly subcutaneous injections of tirzepatide yield reductions in hemoglobin A1c (HbA1c) and body weight compared with insulin lispro, according t…
Learn MoreDiabetes More Prevalent in Black Patients With Multiple Myeloma
FRIDAY, Oct. 6, 2023 (HealthDay News) — Diabetes mellitus (DM) is more prevalent among Black patients with multiple myeloma (MM) and is associated with overall survival in MM, especially among White patients, according to a study published online Sep…
Learn MorePsychotropic Medication Use Up in Children, Teens With Type 1 Diabetes
THURSDAY, Oct. 5, 2023 (HealthDay News) — Dispensing of psychotropic medication increased among children and adolescents with type 1 diabetes (T1D) from 2006 to 2019, according to a study published online Oct. 3 in JAMA Network Open.Shengxin Liu, fro…
Learn MoreLa terapia con células madre podría ser un avance contra la diabetes tipo 1
MIÉRCOLES, 4 de octubre de 2023 (HealthDay News) — Las personas con diabetes tipo 1 carecen de células funcionales de los islotes en su páncreas para producir la hormona insulina y deben recibirla diariamente a través de inyecciones o una bomba conti…
Learn MoreTirzepatide Bests Semaglutide for Patients With Type 2 Diabetes
THURSDAY, Oct. 5, 2023 (HealthDay News) — Tirzepatide is superior to semaglutide for both blood sugar control and weight loss among people with type 2 diabetes, according to research presented at the European Association for the Study of Diabetes Ann…
Learn MoreTirzepatide Bests Semaglutide for Patients With Type 2 Diabetes
THURSDAY, Oct. 5, 2023 (HealthDay News) — Tirzepatide is superior to semaglutide for both blood sugar control and weight loss among people with type 2 diabetes, according to research presented at the European Association for the Study of Diabetes Ann…
Learn MoreDiabetes Diagnosis by Age 30 Could Shave 14 Years Off Your Life
THURSDAY, Oct. 5, 2023 (HealthDay News) — Rates of diabetes in younger adults are rising globally — and it could be shortening life spans.A diagnosis of type 2 diabetes at age 30 can cut life expectancy by up to 14 years, according to findings from a…
Learn MoreLos consumidores de té podrían tener un mejor control del azúcar en sangre
MIÉRCOLES, 4 de octubre de 2023 (HealthDay News) – Beber té oscuro diariamente podría ayudar a equilibrar los niveles de azúcar en sangre y prevenir la diabetes tipo 2, la forma de la enfermedad más estrechamente relacionada con la obesidad.Este es el…
Learn MoreDurable Reductions in HbA1c, Body Weight Seen With Semaglutide
WEDNESDAY, Oct. 4, 2023 (HealthDay News) — Use of once-weekly subcutaneous semaglutide is associated with sustained reductions in hemoglobin A1c (HbA1c) and body weight, according to a study presented at the annual meeting of the European Association…
Learn MoreStem Cell Therapy Could Be Breakthrough Against Type 1 Diabetes
WEDNESDAY, Oct. 4, 2023 (HealthDay News) — People with type 1 diabetes lack functional islet cells in their pancreas to produce the hormone insulin and must take daily insulin via injections or a continuous pump to compensate.But if new research pans…
Learn More